Breast Cancer Recurrence following Prosthetic, Postmastectomy Reconstruction: Incidence, Detection, and Treatment
Authors:
- Colleen M. McCarthyCMColleen M. McCarthy
- Andrea L. PusicAPAndrea L. Pusic
- Lisa SclafaniLSLisa Sclafani
- Claire BuchananCBClaire Buchanan
- Jane V. FeyJFJane V. Fey
- Joseph J. DisaJDJoseph J. Disa
- Babak J. MehraraBMBabak J. Mehrara
- Peter G. CordeiroPCPeter G. Cordeiro
- 1 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 121 (2) , 381-388
Abstract
The purpose of this study was to evaluate the influence of prosthetic reconstruction on the incidence, detection, and management of locoregional recurrence following mastectomy for invasive breast cancer. A matched retrospective cohort study was performed. Only patients with invasive breast cancer who had 2 years or more of follow-up and/or patients who had recurrence within 2 years of their primary cancer were included. In total, 618 patients who underwent mastectomy for invasive breast cancer from 1995 until 1999 were evaluated. Three hundred nine patients who had immediate, tissue expander/implant reconstruction were matched to 309 women who underwent mastectomy alone on the basis of age (±5 years) and breast cancer stage (I, II, or III). The incidence of locoregional recurrence following mastectomy was 6.8 percent in patients who had reconstruction and 8.1 percent in patients who had mastectomy alone (log rank p = 0.6015). Median time to detection of a locoregional recurrence was 2.3 years (range, 0.1 to 7.2 years) in the reconstructed cohort and 1.9 years (range, 0.1 to 8.8 years) in the nonreconstructed cohort (p = 0.733). Permanent implants were removed following infection in one patient and patient request in two. These results suggest that there is no difference in the incidence of locoregional recurrence in breast cancer patients who undergo immediate, tissue expander/implant reconstruction compared with those patients who do not have reconstruction. Prosthetic breast reconstruction does not appear to hinder detection of locoregional cancer recurrence. In the majority of patients, management of locoregional recurrence does not necessitate removal of a permanent prosthesis.Keywords
This publication has 25 references indexed in Scilit:
- Local Recurrence of Breast Cancer after Skin-Sparing Mastectomy Following Core Needle Biopsy: Case Reports and Review of the LiteratureThe Breast Journal, 2006
- The oncological implications of immediate breast reconstructionEuropean Journal of Surgical Oncology, 2004
- Impact of Immediate Reconstruction on the Local Recurrence of Breast Cancer After MastectomyAnnals of Plastic Surgery, 2003
- Revision of the American Joint Committee on Cancer Staging System for Breast CancerJournal of Clinical Oncology, 2002
- Current surgical management of breast cancerCurrent Opinion in Obstetrics and Gynecology, 2002
- Retrospective Study of the Skin-Sparing Mastectomy in Breast ReconstructionPlastic and Reconstructive Surgery, 1999
- Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.Journal of Clinical Oncology, 1998
- Prognostic classification of breast ductal carcinoma-in-situThe Lancet, 1995
- Comparison of postoperative wound complications and early cancer recurrence between patients undergoing mastectomy with or without immediate breast reconstructionThe American Journal of Surgery, 1993
- Regression of Local and Distant Tumor Growth by Tissue ExpansionPlastic and Reconstructive Surgery, 1991